Last week this drug was approved by NICE for use first line along with the TNF inhibitors adalimumab, etanercept, infliximab, certolizumab pegol and golimumab for patients with severe Rheumatoid Arthritis resistant to conventional treatment with 2 or more DMARDs (Disease …